High-rolling investors have positioned themselves bearish on Axon Enterprise AXON, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in AXON often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 9 options trades for Axon Enterprise. This is not a typical pattern.
The sentiment among these major traders is split, with 22% bullish and 33% bearish. Among all the options we identified, there was one put, amounting to $63,500, and 8 calls, totaling $287,119.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $270.0 to $840.0 for Axon Enterprise over the last 3 months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Axon Enterprise's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Axon Enterprise's whale trades within a strike price range from $270.0 to $840.0 in the last 30 days.
Axon Enterprise 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
AXON | PUT | TRADE | BEARISH | 01/16/26 | $159.0 | $155.5 | $158.75 | $700.00 | $63.5K | 10 | 4 |
AXON | CALL | TRADE | BEARISH | 01/17/25 | $17.3 | $15.7 | $16.02 | $610.00 | $48.0K | 141 | 95 |
AXON | CALL | TRADE | BULLISH | 01/15/27 | $96.5 | $92.5 | $95.49 | $840.00 | $38.1K | 0 | 4 |
AXON | CALL | TRADE | NEUTRAL | 01/16/26 | $118.0 | $114.6 | $116.2 | $620.00 | $34.8K | 26 | 3 |
AXON | CALL | TRADE | NEUTRAL | 01/16/26 | $349.0 | $344.0 | $346.73 | $280.00 | $34.6K | 64 | 0 |
About Axon Enterprise
Axon Enterprise Inc develops, manufactures, and sells conducted energy devices and cloud-based digital evidence management software designed for use by law enforcement, corrections, military forces, private security personnel, and private individuals for personal defense. The company operates in two segments: Taser and software & sensors. Taser develops and sells CEDs used for protecting users and virtual reality training. Software and sensors manufacture fully integrated hardware and cloud-based software solutions such as body cameras, automated license plate reading, and digital evidence management systems. Axon delivers its products worldwide and derives the majority of its revenue from the software & sensors segment and geographically from the United States.
Where Is Axon Enterprise Standing Right Now?
- With a trading volume of 106,251, the price of AXON is up by 1.54%, reaching $605.67.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 53 days from now.
Professional Analyst Ratings for Axon Enterprise
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $800.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Baird persists with their Outperform rating on Axon Enterprise, maintaining a target price of $800.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Axon Enterprise with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.